Medication Description: Leacadinum
LEACADINE (Leacadinum). 2-Carbamoyl aziridine.
White fine crystalline powder.
Easily soluble in water, moderately - in alcohol.
The drug has an immunocorrective effect. In addition to the immunostimulating effect, it increases the cytotoxicity of killer cells and monocytes, inhibiting the growth of tumors.
Lacadin is used in adults as an immunostimulating agent in combination therapy for oncological diseases.
Enter intravenously at the rate of 100 - 300 mg / m 'daily for 10 to 15 days.
Immediately before use, dissolve the contents of the vial in 20 to 40 ml of isotonic sodium chloride solution.
If necessary, leacadin treatment is repeated at 3-week intervals.
When using lekadin possible nausea, vomiting, leukopenia, thrombocytopenia, increased blood pressure. In this case, you should reduce the dose or cancel the drug.
Leacadin is contraindicated in leukopenia (below 3 o 10 ~ / l), thrombocytopenia (below 12 * 10 9 / l), gastric ulcer and duodenal ulcer, hypertension II - III stage, thrombophlebitis in the acute phase.
Product form: lyophilized powder in vials of 0.1 and 0.5 g and vampules of 0.1 g (Leacadinum lyophilisatum 0.1 - 0.5 pro injectionibus).
Storage: List B. In the dark place at a temperature of not more than + 5 C.